Pomalidomide, bortezomib, and dexamethasone for multiple myeloma previously treated with lenalidomide (OPTIMISMM): outcomes by prior treatment at first relapse

Meletios Dimopoulos; Katja Weisel; Philippe Moreau; Larry D. Anderson; Darrell White; Jesus San-Miguel; Pieter Sonneveld; Monika Engelhardt; Matthew Jenner; Alessandro Corso; Jan Dürig; Michel Pavic; Morten Salomo; Eva Casal; Shankar Srinivasan; Xin Yu; Tuong Vi Nguyen; Tsvetan Biyukov; Teresa Peluso; Paul Richardson

doi:10.1038/s41375-020-01021-3

Pomalidomide, bortezomib, and dexamethasone for multiple myeloma previously treated with lenalidomide (OPTIMISMM): outcomes by prior treatment at first relapse

Meletios Dimopoulos, Katja Weisel, Philippe Moreau, Larry D. Anderson, Darrell White, Jesus San-Miguel, Pieter Sonneveld, Monika Engelhardt, Matthew Jenner, Alessandro Corso, Jan Dürig, Michel Pavic, Morten Salomo, Eva Casal, Shankar Srinivasan, Xin Yu, Tuong Vi Nguyen, Tsvetan Biyukov, Teresa Peluso, Paul Richardson

科研成果: 期刊稿件 › 文章 › 同行评审

42 引用（Scopus）

源语言	英语
页（从-至）	1722-1731
页数	10
期刊	Leukemia
卷	35
期	6
DOI	https://doi.org/10.1038/s41375-020-01021-3
出版状态	已出版 - 6月 2021
已对外发布	是

!!!ASJC Scopus Subject Areas

血液学
肿瘤学
癌症研究

联合国可持续发展目标

此成果有助于实现下列可持续发展目标：

访问文件

10.1038/s41375-020-01021-3

其它文件与链接

引用此

Dimopoulos, M., Weisel, K., Moreau, P., Anderson, L. D., White, D., San-Miguel, J., Sonneveld, P., Engelhardt, M., Jenner, M., Corso, A., Dürig, J., Pavic, M., Salomo, M., Casal, E., Srinivasan, S., Yu, X., Nguyen, T. V., Biyukov, T., Peluso, T., & Richardson, P. (2021). Pomalidomide, bortezomib, and dexamethasone for multiple myeloma previously treated with lenalidomide (OPTIMISMM): outcomes by prior treatment at first relapse. Leukemia, 35(6), 1722-1731. https://doi.org/10.1038/s41375-020-01021-3

Dimopoulos, M, Weisel, K, Moreau, P, Anderson, LD, White, D, San-Miguel, J, Sonneveld, P, Engelhardt, M, Jenner, M, Corso, A, Dürig, J, Pavic, M, Salomo, M, Casal, E, Srinivasan, S, Yu, X, Nguyen, TV, Biyukov, T, Peluso, T & Richardson, P 2021, 'Pomalidomide, bortezomib, and dexamethasone for multiple myeloma previously treated with lenalidomide (OPTIMISMM): outcomes by prior treatment at first relapse', Leukemia, 卷 35, 号码 6, 页码 1722-1731. https://doi.org/10.1038/s41375-020-01021-3

@article{3303ceaa6abd48b49513b3a5ae8b3cc0,

title = "Pomalidomide, bortezomib, and dexamethasone for multiple myeloma previously treated with lenalidomide (OPTIMISMM): outcomes by prior treatment at first relapse",

author = "Meletios Dimopoulos and Katja Weisel and Philippe Moreau and Anderson, {Larry D.} and Darrell White and Jesus San-Miguel and Pieter Sonneveld and Monika Engelhardt and Matthew Jenner and Alessandro Corso and Jan D{\"u}rig and Michel Pavic and Morten Salomo and Eva Casal and Shankar Srinivasan and Xin Yu and Nguyen, {Tuong Vi} and Tsvetan Biyukov and Teresa Peluso and Paul Richardson",

note = "Publisher Copyright: {\textcopyright} 2020, The Author(s).",

year = "2021",

month = jun,

doi = "10.1038/s41375-020-01021-3",

language = "English",

volume = "35",

pages = "1722--1731",

journal = "Leukemia",

issn = "0887-6924",

publisher = "Nature Publishing Group",

number = "6",

}

TY - JOUR

T1 - Pomalidomide, bortezomib, and dexamethasone for multiple myeloma previously treated with lenalidomide (OPTIMISMM)

T2 - outcomes by prior treatment at first relapse

AU - Dimopoulos, Meletios

AU - Weisel, Katja

AU - Moreau, Philippe

AU - Anderson, Larry D.

AU - White, Darrell

AU - San-Miguel, Jesus

AU - Sonneveld, Pieter

AU - Engelhardt, Monika

AU - Jenner, Matthew

AU - Corso, Alessandro

AU - Dürig, Jan

AU - Pavic, Michel

AU - Salomo, Morten

AU - Casal, Eva

AU - Srinivasan, Shankar

AU - Yu, Xin

AU - Nguyen, Tuong Vi

AU - Biyukov, Tsvetan

AU - Peluso, Teresa

AU - Richardson, Paul

PY - 2021/6

Y1 - 2021/6

UR - http://www.scopus.com/inward/record.url?scp=85090306164&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85090306164&partnerID=8YFLogxK

U2 - 10.1038/s41375-020-01021-3

DO - 10.1038/s41375-020-01021-3

M3 - Article

C2 - 32895455

AN - SCOPUS:85090306164

SN - 0887-6924

VL - 35

SP - 1722

EP - 1731

JO - Leukemia

JF - Leukemia

IS - 6

ER -

Pomalidomide, bortezomib, and dexamethasone for multiple myeloma previously treated with lenalidomide (OPTIMISMM): outcomes by prior treatment at first relapse

!!!ASJC Scopus Subject Areas

联合国可持续发展目标

访问文件

其它文件与链接

指纹

引用此